黴漿菌檢測市場規模、佔有率和成長分析（按產品、技術、應用、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，全球黴漿菌檢測市場規模將達到 8.9733 億美元，到 2025 年將成長至 9.6732 億美元，到 2033 年將成長至 17.6409 億美元，預測期（2026-2033 年將成長至 17.6409 億美元，預測期（2026-2033 年）的複合年成長率為 7.8%。

由於製藥和生物技術領域的污染案例不斷增加，黴漿菌檢測市場預計將迎來顯著成長。活性化的監測活動和生物製藥行業的需求正顯著推動黴漿菌檢測套組的需求。在新興市場，醫療基礎設施的改善、未被滿足的醫療需求以及黴漿菌污染的高發生率均促進了這一成長。監管機構對生物製藥和疫苗的嚴格檢測要求進一步推動了生物製藥行業的需求。此外，技術進步使得檢測方法更加快速和準確，從而進一步擴大了市場。值得一提的創新包括高靈敏度檢測技術，該技術提高了生物基質中的檢測準確性，並進一步凸顯了高效黴漿菌檢測解決方案在業界的重要性。

推動全球黴漿菌檢測市場發展的因素

全球黴漿菌檢測市場正經歷顯著成長，這主要得益於生物技術和製藥行業研發需求的不斷成長，尤其是疫苗和細胞療法等生物製藥開發需求的日益增加。隨著研究人員在生產過程中越來越依賴細胞株，確保這些細胞株係不含黴漿菌污染至關重要。企業越來越重視研發活動的品質保證，從而推動了對嚴格檢測方法的需求。這種對維持高標準研發營運的日益重視，進一步刺激了對黴漿菌檢測服務的需求。

限制全球黴漿菌檢測市場的因素

全球黴漿菌檢測市場面臨的主要挑戰之一是缺乏精通現代調查方法的專業技術人員。有效的黴漿菌檢測依賴先進技術，而這些技術需要專業的知識和技能。缺乏訓練有素的人員會阻礙這些檢測方案的廣泛應用。在資源和培訓計畫有限的開發中國家，這個問題尤其突出，進一步加劇了技能差距。因此，這可能會阻礙黴漿菌檢測產業的整體發展和成長，並限制其在各個地區的潛力。

全球黴漿菌檢測市場趨勢

全球黴漿菌檢測市場正呈現檢查室操作自動化程度顯著提高的趨勢。自動化系統透過大幅縮短檢測時間、提高生產效率和最大限度地減少人為錯誤，正在革新黴漿菌檢測。這項轉變的驅動力在於生物製藥公司日益重視提高營運效率和維持流程品質的穩定性。隨著這些公司尋求可靠、快速的檢測解決方案，對先進黴漿菌檢測技術的需求持續成長，鞏固了自動化作為市場發展和轉型關鍵驅動力的地位。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究
• 技術分析

全球黴漿菌檢測市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 裝置
• 試劑盒和試劑
  • PCR檢測
  • 核酸檢測試劑盒
  • 染料
  • 拆卸工具包
  • 標準與控制
  • 其他
• 服務

全球黴漿菌檢測市場規模（依技術及複合年成長率分類）（2026-2033 年）

• PCR
• ELISA
• 直接法
• 間接法
• 微生物培養技術
• 酵素法

全球黴漿菌檢測市場規模（按應用領域分類）及複合年成長率（2026-2033 年）

• 細胞株檢測
• 病毒檢測
• 停止細胞測試
• 其他

全球黴漿菌檢測市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 學術研究機構
• 細胞庫
• 合約研究機構
• 製藥和生物技術公司
• 其他

全球黴漿菌檢測市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Thermo Fisher Scientific Inc.（USA）
• Merck KGaA（Germany）
• Lonza Group Ltd.（Switzerland）
• Charles River Laboratories International Inc.（USA）
• Eurofins Scientific SE（Luxembourg）
• Roche Diagnostics（Switzerland）
• Agilent Technologies Inc.（USA）
• Bio-Rad Laboratories Inc.（USA）
• Sartorius AG（Germany）
• bioMerieux SA（France）
• Asahi Kasei Corporation（Japan）
• American Type Culture Collection（ATCC）（USA）
• Bionique Testing Laboratories Inc.（USA）
• InvivoGen（USA）
• PromoCell GmbH（Germany）
• Biological Industries Israel Beit Haemek Ltd.（Israel）
• Creative Bioarray（USA）
• Mycoplasma Experience（UK）
• Norgen Biotek Corp.（Canada）
• Biotools B & M Labs SA（Spain）

結論與建議

Global Mycoplasma Testing Market size was valued at USD 897.33 Million in 2024 and is poised to grow from USD 967.32 Million in 2025 to USD 1764.09 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The mycoplasma testing market is poised for significant growth, driven by rising contamination incidents in the pharmaceutical and biotechnology sectors. The demand for mycoplasma testing kits is notably increasing, fueled by intensified research initiatives and the biopharmaceutical industry's requirements. Emerging markets are contributing to this growth due to improved healthcare infrastructure, unmet healthcare needs, and a higher prevalence of mycoplasma contamination. Regulatory bodies are enforcing stringent testing mandates for biologics and vaccines, further fueling demand in the biopharmaceutical arena. Additionally, advancements in technology are enhancing the market, introducing faster and more accurate testing methods. Notable innovations include highly sensitive assays, improving detection in biological matrices and reinforcing the importance of effective mycoplasma testing solutions in the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycoplasma Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycoplasma Testing Market Segments Analysis

Global Mycoplasma Testing Market is segmented by Product, Technology, Application, End-User and region. Based on Product, the market is segmented into Instruments, Kits & Reagents and Services. Based on Technology, the market is segmented into PCR, ELISA, Direct Assay, Indirect Assay, Microbial Culture Techniques and Enzymatic Methods. Based on Application, the market is segmented into Cell Line Testing, Virus Testing, End of Production Cells Testing and Others. Based on End-User, the market is segmented into Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mycoplasma Testing Market

The global market for mycoplasma testing is experiencing significant growth, primarily fueled by the rising demand for research and development in the biotechnology and pharmaceutical sectors, particularly in the creation of biological products, such as vaccines and cell-based therapies. As researchers increasingly depend on cell lines for their manufacturing processes, ensuring that these cell lines are free from mycoplasma contamination has become essential. Companies are placing a greater emphasis on quality assurance in their research activities, driving the need for stringent testing methods. This increased focus on maintaining high standards in research operations is further propelling the demand for mycoplasma testing services.

Restraints in the Global Mycoplasma Testing Market

One significant challenge facing the global mycoplasma testing market is the shortage of skilled professionals proficient in contemporary testing methodologies. Effective mycoplasma testing relies on advanced techniques that necessitate specialized knowledge and expertise. The insufficient availability of adequately trained personnel can impede the widespread adoption and implementation of these testing solutions. This issue is particularly pronounced in developing countries, where access to resources and training programs is often limited, further exacerbating the skill gap. As a result, the overall progress and growth of the mycoplasma testing industry may be adversely affected, hindering its potential in various regions.

Market Trends of the Global Mycoplasma Testing Market

The Global Mycoplasma Testing market is experiencing a significant trend towards the integration of automation in laboratory operations. Automated systems are revolutionizing mycoplasma testing by drastically reducing testing times, enhancing productivity, and minimizing human errors. This shift is propelled by the increasing focus of biopharmaceutical companies on improving operational efficiency and maintaining consistent quality in their processes. As these companies seek reliable and rapid testing solutions, the demand for advanced mycoplasma testing technologies continues to grow, solidifying the role of automation as a key driver in the market's evolution and transformation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Mycoplasma Testing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Kits & Reagents
  • PCR Assays
  • Nucleic Acid Detection Kits
  • Stains
  • Elimination Kits
  • Standards & Controls
  • Others
• Services

Global Mycoplasma Testing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• PCR
• ELISA
• Direct Assay
• Indirect Assay
• Microbial Culture Techniques
• Enzymatic Methods

Global Mycoplasma Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cell Line Testing
• Virus Testing
• End of Production Cells Testing
• Others

Global Mycoplasma Testing Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Academic Research Institutes
• Cell Banks
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Others

Global Mycoplasma Testing Market Size & CAGR (2026-2033)

• North America (Product, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Type Culture Collection (ATCC) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionique Testing Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InvivoGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological Industries Israel Beit Haemek Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mycoplasma Experience (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotools B & M Labs S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations